Pharma news

Reset all filters
Geography
Company
Refine search
DoJ sues company for selling unapproved drugs and supplements
Americas
The US Department of Justice has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements.   21 February 2017
Licensing tips from a patent litigator
Americas
Anyone drafting patent licence agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.   21 February 2017
Novartis in $1bn cardiovascular deal with Ionis and Akcea
Americas
Novartis has finalised its agreement with biopharmaceutical company Ionis Pharmaceuticals and its wholly-owned subsidiary Akcea Therapeutics to develop and commercialise therapies for cardiovascular disorders.   20 February 2017
Americas
The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug.   16 February 2017
Asia-Pacific
India-based Initiative for Medicines, Access & Knowledge has filed four patent challenges against patents covering hepatitis C drugs in a bid to ensure access to affordable treatment.   15 February 2017
Americas
Chosun University in Korea has taken on EMD Millipore, a life sciences subsidiary of Merck, in a patent infringement claim centring on derivatives of thiazolidinedione.   15 February 2017
Americas
AstraZeneca has filed a patent infringement claim against Dr Reddy's Laboratories over the drug Faslodex (fulvestrant) intramuscular injection, a treatment for breast cancer.   14 February 2017
Americas
The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.   13 February 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed and remanded a decision by a district court centring on the drug Lialda, a treatment for ulcerative colitis.   13 February 2017
Americas
The US Court of Appeals for the Second Circuit has partly revived a competition case against Takeda that accuses the company of delaying generic versions of its diabetes drug Actos.   13 February 2017